CLINICAL_TRIALS
trial_result
· 2013-04-23
Clinical Trial Update: Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes [Phase 2]
Summary
Pfizer completed a Phase 2 trial evaluating the safety and efficacy of PF-04991532 in adults with type 2 diabetes; results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2013-04-23